Last reviewed: July 16, 2026
Last updated: July 16, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
The Mounjaro KwikPen is a pre-filled injection device designed for tirzepatide, a GLP-1 and GIP receptor agonist that produces meaningful weight loss through appetite regulation and improved metabolic signaling. Each pen contains either 1.34 mg, 2.68 mg, 4.02 mg, or 5.67 mg of tirzepatide depending on the strength selected—with typical titration protocols requiring progression over 16 weeks to reach therapeutic maintenance doses. PlexusDx provides compounded tirzepatide injections through licensed 503A pharmacies, making this powerful medication accessible across all 50 states without insurance requirements.
Start your GLP-1 program with PlexusDx
One all-inclusive price covers your online provider visit, prescription, compounded medication, and shipping — no membership, no hidden fees. Complete a short intake and a licensed provider takes it from there.
Start your intake →
Understanding Tirzepatide Pen Dosage Strengths
Tirzepatide comes in four single-dose strengths within pre-filled injection pens. The starting dose is typically 0.5 mg, which may be delivered through a pen containing 1.34 mg (allowing multiple uses through careful measurement). Each subsequent pen strength—2.68 mg, 4.02 mg, and 5.67 mg—allows progression through the standard titration schedule. This design lets patients move forward in their treatment without changing injection technique or relearning device operation.
The number of individual injections per pen varies based on how the medication is calibrated and whether the prescription uses single-dose or multi-dose approaches. Licensed compounding pharmacies can prepare tirzepatide in concentrations tailored to individual patient schedules, optimizing both convenience and medication stability. PlexusDx works exclusively with 503A compounding partners to ensure pharmaceutical-grade purity and consistent dosing accuracy across your entire treatment course.
Standard Tirzepatide Titration Schedule and Dose Progression
Most patients follow a 16-week titration protocol beginning with 0.5 mg weekly, increasing by 0.5 mg every 4 weeks until reaching a maintenance dose between 5 mg and 15 mg weekly. This gradual escalation allows your body to adapt to the medication while minimizing nausea and gastrointestinal side effects common during rapid dose increases. Each step in this progression may correspond to a new pen strength or a new compounded vial, depending on your treatment plan.
Maintenance doses typically stabilize at 5 mg, 10 mg, or 15 mg weekly based on individual tolerability, weight loss response, and metabolic markers. Some patients achieve their target weight loss at lower maintenance doses, while others benefit from the maximum approved dose. Your PlexusDx healthcare provider adjusts your prescription as you progress, ensuring your medication matches your body's changing needs throughout treatment.
How PlexusDx Compounded Tirzepatide Differs from Brand Pens
Brand Mounjaro pens are pre-filled by the manufacturer at fixed strengths, requiring patients to purchase new pens at each titration step. PlexusDx compounded tirzepatide, prepared by licensed 503A pharmacies, can be customized to your exact dose and frequency, reducing waste and simplifying your injection schedule. Instead of managing multiple pens, you may receive single-strength vials matched precisely to your current protocol.
Compounded tirzepatide undergoes the same quality testing and sterility standards as brand medications but arrives at a flat monthly rate at $289/mo month-to-month, or from $249/mo on the 6-month plan—never tied to dose level. This pricing transparency means you won't see your bill increase as your therapeutic dose climbs during titration. PlexusDx serves all 50 states without insurance, membership fees, or prior authorization delays that sometimes slow access to brand products.
Optimizing Your Tirzepatide Treatment with Genetic Insights
The PlexusDx Precision Peptide Genetic Test analyzes GLP1R (rs6923761), and GIPR (rs1800437) — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to tirzepatide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.
After your first month of PlexusDx treatment, adding the Precision Peptide Genetic Test ($99) maps 14 metabolic pathways and 150+ genetic insights specific to your tirzepatide response. Patients with favorable genetic markers often reach target weight loss faster, while those with different pathway signatures may benefit from longer titration schedules or combination approaches. This precision-guided approach maximizes your outcomes while keeping your monthly medication cost flat as your dose advances.
How Your Genetics Relate to GLP-1 Pathways
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection is $289/mo month-to-month, or from $249/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
How many injection days are included in one tirzepatide pen?
A single pre-filled tirzepatide pen typically supports 1-4 weeks of dosing depending on its strength and your titration stage. PlexusDx compounded tirzepatide is prepared in vials that match your specific weekly dose, so you receive exactly what you need for your current protocol without waste or inventory confusion.
Does tirzepatide dosing stop at 15 mg, or can patients go higher?
The maximum approved tirzepatide maintenance dose is 15 mg weekly based on clinical trial data from the SURMOUNT trials, which showed sustained weight loss plateaus at this level in most patients. Licensed 503A compounding pharmacies can prepare tirzepatide at any prescribed dose; your PlexusDx provider will recommend the optimal maintenance strength based on your response and tolerability.
Will my PlexusDx cost increase as my tirzepatide dose goes up during titration?
No. PlexusDx compounded tirzepatide injections are $289/mo month-to-month, or from $249/mo on the 6-month plan with flat pricing across all dose levels—your dose may need to go up, your price won't. This eliminates surprises as you progress through titration and helps you budget for long-term weight loss treatment.
What happens if I experience side effects early in my tirzepatide titration?
Mild nausea and appetite suppression are expected as your body adjusts to tirzepatide; these often resolve within 1-2 weeks at each dose level. If side effects persist or become severe, your PlexusDx provider can pause titration, extend your timeline at the current dose, or recommend supportive strategies. Compounded tirzepatide allows dose adjustments without switching devices or restarting prescriptions.
How does the Precision Peptide Genetic Test relate to your GLP-1 pathway?
The PlexusDx Precision Peptide Genetic Test identifies variants in your GLP1R, GIPR, and other metabolic genes that influence how strongly you respond to tirzepatide signaling. Patients with genetic patterns favoring robust GLP-1 receptor activation often see faster weight loss and may reach maintenance doses with fewer side effects, enabling more personalized titration planning.
Related Reading
Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Should I Eat Breakfast on Mounjaro for Optimal Weight Loss?
Does Mounjaro Skin Sensitivity Go Away? What You Need to Know